Back to Journals » OncoTargets and Therapy

SJR OA
CiteScore
Impact Factor

OncoTargets and Therapy

ISSN: 1178-6930


       

Editor-in-Chief: Professor Gaetano Romano

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Articles:

Latest articles:

- 5 records -

Original Research

Investigating the Cell Origin and Liver Metastasis Factors of Colorectal Cancer by Single-Cell Transcriptome Analysis

Sha Z, Gao Q, Wang L, An N, Wu Y, Wei D, Wang T, Liu C, Shen Y

OncoTargets and Therapy 2024, 17:345-358

Published Date: 17 April 2024

Case report

A Case Study of Gastric Adenocarcinoma and Squamous Cell Carcinoma of the Cervix

Liu S, Li F, Cao Q, Li N, Gao Q

OncoTargets and Therapy 2024, 17:339-344

Published Date: 15 April 2024

Case report

Primary Epithelioid Angiosarcoma of the Jejunal Mesentery Causing Abdominal Bleeding: Case Report and Literature Review

Yang P, Wu Q, Zhou Y, Li Y

OncoTargets and Therapy 2024, 17:327-338

Published Date: 10 April 2024

Review

Traditional Chinese Medicine in Regulating Tumor Microenvironment

Wang Z, Li M, Bi L, Hu X, Wang Y

OncoTargets and Therapy 2024, 17:313-325

Published Date: 10 April 2024

Case report

MAP2K1 K57N Conferred an Acquired Resistance to Furmonertinib, Dabrafenib and Trametinib Combined Therapy in Advanced Lung Adenocarcinoma with EGFR Mutation and BRAF V600E

Tan X, Wu Z, Chen M

OncoTargets and Therapy 2024, 17:307-312

Published Date: 9 April 2024


Read more articles